The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 22, 2016

Filed:

May. 20, 2013
Applicants:

David a Scheinberg, New York, NY (US);

Michael R Mcdevitt, Bronx, NY (US);

Dangshe MA, Millwood, NY (US);

George Sgouros, Ellicott City, MD (US);

Inventors:

David A Scheinberg, New York, NY (US);

Michael R McDevitt, Bronx, NY (US);

Dangshe Ma, Millwood, NY (US);

George Sgouros, Ellicott City, MD (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 51/10 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 51/1096 (2013.01); A61K 51/1027 (2013.01); A61K 51/1045 (2013.01); A61K 51/1069 (2013.01); A61K 51/1072 (2013.01); C07K 16/2803 (2013.01); C07K 16/3069 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); C07K 2317/24 (2013.01); C07K 2317/77 (2013.01);
Abstract

The present invention discloses methods for treating non-malignant cell diseases by administering to an individual a construct comprising actinium-225 or bismuth-213 and an antigen of a non-malignant cell. Also, provided is a method for treating a solid tumor associated with an abnormal proliferation of cells by targeting an antigen of the tumor-associated vasculature with the constructs.


Find Patent Forward Citations

Loading…